$ONCY Cashflow Statement | Understand Stock

$ONCY

$0.47 -$0.03 (5.79%) Close

$ONCY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of CAD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net loss for the year
Depreciation - property and equipment (notes 6, 20)
Depreciation - right-of-use assets (notes 8, 20)
Share-based compensation expense (notes 11, 20, 22)
Interest expense on lease liabilities (note 7)
Compensation warrant expenses (note 11)
Interest expense (income), net
Unrealized foreign exchange (gain) loss
Change in fair value of warrant derivative (notes 9, 17)
Net change in non-cash working capital (note 18)
Cash used in operating activities
Acquisition of marketable securities
Maturities of marketable securities
Acquisition of property and equipment (note 6)
Cash (used in) provided by investing activities
Proceeds from exercise of stock options (note 11)
Proceeds from exercise of warrant derivative (note 9)
Proceeds from share issuance
Warrant Derivative and Shares Under Warrant Agreement
Shares Under Common Stock Purchase Agreement
At-the-market equity distribution agreement
Public offering

Payment of lease liabilities (note 8)
Cash provided by financing activities
(Decrease) increase in cash and cash equivalents
Impact of foreign exchange on cash and cash equivalents
Cash flows from operating activities:
Net loss
Noncash adjustments reconciling net loss to cash flows from operating activities:
Depreciation of property and equipment
Noncash lease expense
Stock-based compensation expense
Issuance of shares for services
Unrealized foreign exchange gains
Change in fair value of warrant derivative
Fair value loss from SEPA Arrangement
Value of shares issued for SEPA Arrangement commitment fees
Changes in operating assets and liabilities:
Other receivables
Prepaid expenses
Accounts payable
Accrued liabilities
Pancreatic Cancer Action Network (“PanCAN”) receivables and payables
Operating lease liabilities
Net cash used in operating activities
Cash flows from investing activities:
Acquisition of property and equipment
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from exercise of warrant derivative
Proceeds from issuance of common stock
ATM Offering Agreements
Issued pursuant to SEPA Arrangement
Proceeds from stock option exercise
Other
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents
Net decrease in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year

Comments